Generic Veramyst is not yet available on the market. As soon as the patent for Veramyst expires in August 2021, however, a number of drug companies will most likely begin manufacturing a generic version of the nasal spray. It is important to note that generic fluticasone propionate nasal spray (a generic version of Flonase) is not the same as generic Veramyst.
Veramyst is manufactured by GlaxoSmithKline. It is currently under the protection of a patent that prevents any generic Veramyst from being manufactured in the United States. It is important to note that generic fluticasone propionate nasal spray is not a generic version of Veramyst (it is a generic version of Flonase®, a similar medication).
When Will Generic Veramyst Be Available?
The first patent for Veramyst currently expires in August 2021. This is the earliest possible date that a generic version of Veramyst could become available. However, there are other circumstances that could come up to extend the exclusivity period of Veramyst beyond 2021. This could include such things as other patents for specific Veramyst uses or lawsuits. Once Veramyst goes off patent, there may be several companies that will begin manufacturing a generic Veramyst drug.
Flonase vs. Veramyst?
Flonase nasal spray is available in generic versions, while Veramyst is not. Many people wonder if there is a difference between these two medications. Both medications contain fluticasone. However, there are some important differences. Veramyst (but not Flonase) has been shown to improve eye allergy symptoms, such as redness, itching, and wateriness. Also, Veramyst is approved for use in children as young as two years old, while Flonase is approved for children age four and older. However, Flonase is approved to treat non-allergic nasal symptoms, while Veramyst is not.
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Last reviewed by: KristiMonson, PharmD;
List of references (click here):
Veramyst [package insert]. Research Triangle Park, NC: GlaxoSmithKline;2007 April.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA web site. Available at: http://www.fda.gov/cder/ob/. Accessed August 1, 2007.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click